by Kathy Jones on  January 18, 2014 at 10:37 PM Research News
 Beta Cell Replication can be Promoted by Targeting a Cell Cycle Inhibitor
The loss of beta cell mass, which results in decreased insulin production, is one of the factors underlying the development of type 2 diabetes.

Once lost, β cell mass cannot be restored. In contrast, infants with focal hyperinsulinism of infancy exhibit rapid expansion of the β cell mass due to a silencing of a region of chromosome 11 that includes the gene encoding the cell cycle inhibitor p57Kip2. In this issue of the Journal of Clinical Investigation, Klaus Kaestner and colleagues at the University of Pennsylvania demonstrate that silencing the gene encoding p57Kip2 in isolated adult human islets promotes β cell replication and that these new cells exhibit many properties associated with β cells. This study provides an explanation for excessive β cell expansion in children with focal hyperinsulinism and suggests that targeting the p57Kip2 pathway in adults with type 2 diabetes may improve β cell function.

Source: Eurekalert

Most Popular on Medindia